Analysts tweak 12-month target prices on Fisher & Paykel Healthcare

Analysts tweak 12-month target prices on Fisher & Paykel Healthcare
(Image: Fisher & Paykel Healthcare)
Rebecca Howard
Analysts rejigged their 12-month target prices on Fisher & Paykel Healthcare after it lifted its full-year guidance but retained fairly downbeat ratings. Last Friday, the healthcare products manufacturer lifted its full-year revenue guidance to $1.73 billion, from $1.7b, and net profit to $260 million-$265m, from $250m-$260m.Forsyth Barr analysts lifted their target price to $23.45 from $22.95. The shares last traded at $26.62.They noted that F&P Healthcare referenced stronger hospital consumables revenue and “homecare r...

More Markets

Freightways outlook and Fonterra vote drive upbeat day
Markets Market Close

Freightways outlook and Fonterra vote drive upbeat day

Freightways shares climbed after Mark Troughear flagged easing economic headwinds.

Tom Raynel 30 Oct 2025
Me Today raises funds to be here tomorrow
Markets

Me Today raises funds to be here tomorrow

Shareholders have approved a capital raise of up to $2.59 million.

Greg Hurrell 30 Oct 2025